\
&
Contact us
\
&
Contact us
Starts in 2 weeks from now
LocationOnline
ProgrammesThe European Commission organises an additional online information session dedicated to the migration research call HORIZON-CL2-2026-01-TRANSFO-08: Strengthened implementation of the EU Pact on Migration and Asylum and a focus on inclusion, integration, and health. This call pursues two main objectives: one is to improve the implementation of the EU Pact on Migration and Asylum through evidence-based insights on migration governance and legal pathways; another is to advance migrant health equity and support effective long-term integration and inclusion policies.
More information on this event can be found here.
For the remaining 2026 calls of Cluster 2 an info day on 26 March took place. The recordings of this info day can be rewatched via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
